F. Wyman Morgan
FMC Corporation, 1991-2005
Director Chemical Technology
- Guided strategy development, opportunity assessment, planning and venture implementation for technology-enabled businesses
- Led the effort to identify new technology platforms for BioPolymer resulting in a new business unit with its own marketing and technical resources; NovaMatrix
- Developed a methodology ("Technology Review and Planning" format) to identify new business opportunities and operational improvements that integrates external market and technology input and aligns commercial, manufacturing and technology functions toward the most attractive business goals while improving morale in the process
- More than 30 reviews conducted on subjects ranging from plant troubleshooting, to cost reduction, to new applications, to pre-construction technology verification, to new technology platforms, to new business opportunities, to potential business strategies, to quality systems, to customer service, to selection of external technology partners, and to organization design
- Assembled R&D effort, identified basic technology (in-licensed) and made breakthrough improvements to arrive at the technology to extract lithium chloride from South American brine sources; A major facility was constructed in Argentina and enjoys an industry low-cost position for lithium chloride
- Led the effort to restore operations in two production plants that experienced major fires and to identify the best future technology directions; Organized and provided the resources to initiate and manage toll manufacture of products displaced from one of the plants that experienced a disabling fire
- Conducted corporate-wide study of the process technology function that led to a reinvigorated and more effective process capability
- Recruited experienced new hires into FMC who rapidly moved into responsible divisional technical and commercial positions
Monsanto Company 1967-1986
R & D Director Bovine Somatotropin (BST) Program. BST is an endogenous protein that improves the efficiency of milk production in dairy cows.
- Initiated and managed Monsanto BST research program from inception to regulatory submission and manufacturing startup.
- Managed technical relationship with Genentech, the supplier of Monsanto's recombinant BST organism.
- Responsible for research on a worldwide basis: formulated long range R&D plans, hired people and built facilities.
- Developed first-of-its-kind sterile, injectable, prolonged-release product for BST and developed a process for production of multi-ton quantities of bulk and finished products.
- Built and managed highly effective and motivated research and development department of more than one hundred scientists and support personnel.
- As a result of effective research and development, Monsanto advanced from a clean-slate start to a leadership position in BST, shutting out established pharmaceutical companies. BST continues to be a successful business
R & D/Process Development Manager
- Managed chemistry research section in Monsanto's anti-cancer drug program and developed a process for an anti-cancer drug. Produced multi-pound quantities of the drug candidate for human clinical trials.
- Developed numerous processes for detergent materials, for example, for a biodegradable ether-poly-carboxylic acid detergent builder, and managed pilot plant production of developmental quantities (up to twenty thousand pounds over four month period).
Human Resource Developmental Manager
- Initiated and led innovative programs in Monsanto's Personnel Function to improve assessment, acquisition, placement and development of technical personnel on a corporation-wide basis; for example, a trend of declining Ph.D. hires was reversed (59% one year increase) and a "first-ever" corporate-wide mechanism for intra-company transfer of technical personnel was put in place.
Education
- Ph.D., Inorganic Chemistry, University of Florida 1967
- BS, Chemistry, Florence State College 1962
